CTS Targets 10% CAGR with Organic and Inorganic Growth

CTS Corporation is positioned to deliver 10% organic and inorganic growth, leveraging a strong balance sheet and cash flow to support its M&A strategy, with a focus on non-transportation end markets and EV technology.

“CTS Positioned to Deliver 10% Organic and Inorganic Growth Deep custom engineered capability and long-standing customer relationships Megatrend tailwinds – automation, healthcare innovation and electrification Strong new product pipeline – eBrakeTM, textured piezo, medical applications Organic Growth 300-600 bps > GDP Clear strategy of growth and diversification led by non-transportation end markets Transportation acquisition focus on EV technology capability Strong balance sheet and cash flow to support M&A strategy”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.